Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 6,164 shares at $54.15 ($334K) on 2019-11-08, disclosed to the SEC on 2019-11-12.
Seasonal sale ($334k) by Director — this insider has traded EBS in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.15 | 3,082 | $167K | 50.0% |
| 2 | $54.15 | 3,082 | $167K | 50.0% |
| Total | $54.15 avg | 6,164 | $334K | 100% |
| Filing → |
| EBS | SELL | 2025-03-12 | $115K | — | Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |